Skip to main content
| News

Bottmedical enters the market with innovative braces

27.07.2021

The Basel-based startup Bottmedical has developed clear aligners made from bio-based polymers. After closing a successful financing round, the company has now entered the market. An increasing number of clinics are now using the innovative braces.

Bottmedical Tino, Marie, Elise, NA
Inspired minds at work (img: Bottmedical)

Bottmedical has developed clear braces made from bio-based polymers, further details of which can be found in an article on startupticker.ch. Founded as a spin-off from the University of Basel and headquartered in Technologiepark Basel, Bottmedical has already supplied its product to customers located across Europe and recently initiated global expansion plans in Japan and Australia. In Switzerland, Naturaligner is available at ever more clinics, while the University of Basel is testing the product’s biomechanical properties in a clinical trial currently in progress.

It was only in April that the Basel-based company closed a financing round by securing gross proceeds in the amount of 1.1 million Swiss francs. At present, a Series B financing round is being prepared for the pending growth phase. The aim here is to ensure that Naturaligner will be available to one million patients at 2024.

“We are pioneers in the field of bio-based polymers for dental medicine. Our aim is to reduce patient exposure to harmful microplastics and plasticizers”, explains Tino Töpper, co-founder and CEO of Bottmedical, in an article with the ‘Basler Zeitung’ newspaper. In the next step, Bottmedical will functionalize the material with antibacterial subsistence to support the prevention of caries foundation.

While Bottmedical is working to expand production capacities, the company is also already focused on the development of its next product. Ultra-thin sensors are designed to function as an interface between the tongue and an app. “The Tofi-Trainer facilitates interactive and entertaining training of the muscle fiber-related tongue motor skills in order to improve the tension and the subconscious control of the tongue at night”, Töpper stated to ‘Basler Zeitung’. In this way, both snoring and sleep apnea could be treated.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

Basel Area Business & Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

South Korean pharma firms show interest in the Basel Area

Several South Korean firms from the life sciences industry, including three pharmaceutical multinationals, have visited the Basel Area on fact-finding...

Read More
Gamma Technologies acquires ProFEMAG portfolio
Advanced Manufacturing/AI, Basel Area Business & Innovation, ICT, Innovation, Invest

Gamma Technologies acquires ProFEMAG portfolio

The Basel-based firm ProFEMAG AG has sold its FEMAG software for electrical machine applications to Gamma Technologies. The company based...

Read More
Basel Area Business & Innovation, ICT, Innovation, Invest, Life Sciences / biotech

Databaum establishes headquarters in Basel

Databaum is establishing its headquarters in Basel and plans to grow from its location there. The startup provides the agricultural...

Read More
Clinerion launches patient information platform
Basel Area Business & Innovation, Digital Health, ICT, Innovation, Invest, Life Sciences / biotech

Clinerion launches patient information platform

Basel-based Clinerion is introducing its machine learning platform. It comprises a global network of hospitals and enables researchers to recognize...

Read More
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

New innovation campus opens in the Basel Area

The Main Campus of the Switzerland Innovation Park Basel Area was officially opened on October 29. In his speech, Federal...

Read More
Sumitovant acquires all shares in Myovant
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Sumitovant acquires all shares in Myovant

Sumitovant is in the process of making Basel-based Myovant Sciences a wholly owned subsidiary by acquiring a 100 percent shareholding...

Read More
1 2 3 59

Do you have a question? We'd like to hear from you.